While glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been demonstrated to be efficacious in weight control in non-cancer populations (2), to date, only one case report assessed the effect of GLP-1 RAs on alectinib-induced weight gain. The gene discussed is GLP1R; the disease is cancer.